FINWIRES · TerminalLIVE
FINWIRES

調査速報:EGはリストラの中、第1四半期決算で賛否両論の結果を発表

By

-- 独立系調査会社CFRAは、に対し、以下の調査レポートを提供しました。CFRAのアナリストは、以下のように見解をまとめています。EGは第1四半期の営業利益(EPS)が前年同期の6.45ドルに対し16.08ドルとなり、当社の予想15.27ドル、市場コンセンサス予想13.96ドルを上回りました。営業収益は、保険料収入の7.2%減と投資収益の15%増により4.4%減少しましたが、コンバインド・レシオは102.7%から91.2%へと大幅に改善しました。当社は、EGの戦略的な事業再編、特に保険料収入の75%以上を占める中核事業である再保険事業に注力するため、小売商業保険事業の更新権を売却したことを高く評価します。EGは2025年から2026年にかけて2億5,000万ドルから3億5,000万ドルの税引前費用を計上する見込みで、54億ドルの負債準備金をカバーする不利な状況への対応策を講じています。しかしながら、EGの引受実績がまちまちであることを考えると、純粋な再保険会社になることが必ずしも企業価値の倍率を高めるとは限らないという懸念が残ります。特に再保険料の軟化が進む環境下では、この戦略には実行リスクがあると見ています。第1四半期のEPSが予想を上回ったとはいえ、現時点では慎重な姿勢を維持しています。

Related Articles

Asia

Electro Optic Systems Reports Contract Backlog Growth as of March 31

Electro Optic Systems Holdings (ASX:EOS) reported a contract backlog of AU$518 million as of March 31, up 13% from the end of 2025, according to a Thursday filing with the Australian bourse.The company closed the March quarter with unrestricted cash holdings of AU$95.1 million, representing a decrease of AU$11.8 million from the end of 2025, per the filing.

$ASX:EOS
Asia

Regis Healthcare Expects Fiscal 2026 Underlying EBITDA at Top End of Guidance

Regis Healthcare (ASX:REG) said it expects fiscal 2026 underlying earnings before interest, taxes, depreciation, and amortization (EBITDA) of about AU$135 million, at the top end of guidance, according to a Thursday Australian bourse filing.Occupancy across mature homes averaged about 96% in the fiscal third quarter, per the filing.The company said it generated net refundable accommodation deposit (RAD) cash inflows of AU$44.5 million in the third quarter, taking the total net RAD cash inflows for the year to date to AU$223 million.As resident turnover occurs, the progressive repricing of existing paid-up RADs to current advertised room prices is expected to generate net operating cash inflows of about AU$400 million over time while also increasing RAD retention earnings, the company added.

$ASX:REG
Research

Research Alert: CFRA Keeps Hold Opinion On Shares Of Mondelez International

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Our 12-month target price of $63, raised $1, reflects a 19x multiple of projected 2027 EPS, in line with MDLZ's historical forward P/E average. We raise our 2026 EPS estimate by $0.06 to $3.08, but cut 2027's by $0.11 to $3.32. We continue to see headwinds related to chocolate and biscuits divisions, though favorable forex has been helping to a degree. MDLZ highlighted plans to stimulate growth with more promotional activity, which could boost revenues (we see an acceleration in revenues in 2027), but may come with the trade-off of narrower margins. We note that cost-saving efforts can also contribute to staving off some of the margin pressure. MDLZ is largely hedged on its cocoa input costs for 2026 but less so in 2027. Thus, if the substantial rise in cocoa pricing in 2025 does not reemerge, it should help the bottom line in 2027 as cost pressures should ease. Share buybacks have also contributed to EPS, and we note that Q1 2026 share count was down 1.5% from one year earlier.

$MDLZ